Clinical Trials

Study Title:
A Phase 2 Study of BA3011 Alone and in Combination with Nivolumab in Adult Patients with Metastatic Non Small Cell Lung Cancer (NSCLC) Who Had Prior Disease Progression on a PD 1/L 1 Inhibitor, EGFR, or ALK Inhibitor

For more information about the trial above please contact the study team:

Principal Investigator, Mariam Alexander, at alexanma@musc.edu.

Study Coordinator, Alexandra Leitner, at leitnera@musc.edu, or please call +1 843-792-1507.

Trial opened at the following institutions: Medical University of South Carolina